Microplasmin Intravitreal Administration in Patients with Vitreomacular Traction Scheduled for Vitrectomy. The MIVI I Trial

Ophthalmology

Volumn 116, Issue 7, 2009, Pages

  de Smet, Marc D ^a   Gandorfer, Arnd ^b   Stalmans, Peter ^c   Veckeneer, Marc ^d   Feron, Eric ^d   Pakola, Steve ^e   Kampik, Anselm ^b  

^a Department of Ophthalmology ^*  (Belgium)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d Oogziekenhuis   (Netherlands)

^e ThromboGenics NV   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MICROPLASMIN; PLASMIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B SCAN; CLINICAL TRIAL; DRUG DOSE ESCALATION; DRUG EFFICACY; ELECTROPHYSIOLOGY; EYE DISEASE; EYE FUNDUS; EYE INFLAMMATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PHOTOGRAPHY; MULTICENTER STUDY; OPHTHALMOLOGY; PARS PLANA VITRECTOMY; PATIENT SAFETY; PHARMACOLOGIC VITREOUS BODY DETACHMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHOTOPSIA; PREOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RETINA MACULOPATHY; TIME; TREATMENT OUTCOME; VISUAL FIELD; VITRECTOMY; VITREOMACULAR TRACTION MACULOPATHY;

EID: 67649487961     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.03.051     Document Type: Article

References (35)

1. Green W.R. The macular hole: histopathologic studies. Arch Ophthalmol 124 (2006) 317-321
2. Sebag J. Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp Ophthalmol 242 (2004) 690-698
3. Johnson M.W. Tractional cystoid macular edema: a subtle variant of the vitreomacular traction syndrome. Am J Ophthalmol 140 (2005) 184-192
4. Levy J., Klemperer I., Belfair N., et al. Rapid spontaneous resolution of vitreomacular traction syndrome documented by optical coherence tomography. Int Ophthalmol 25 (2004) 247-251
5. Haritoglou C., Gass C.A., Schaumberger M., et al. Macular changes after peeling of the internal limiting membrane in macular hole surgery. Am J Ophthalmol 132 (2001) 363-368
6. Russell S.R., and Hageman G.S. Optic disc, foveal, and extrafoveal damage due to surgical separation of the vitreous. Arch Ophthalmol 119 (2001) 1653-1658
7. Badrinath S.S., Gopal L., Sharma T., et al. Vitreoschisis in Eales' disease: pathogenic role and significance in surgery. Retina 19 (1999) 51-54
8. Sebag J. Diabetic vitreopathy. Ophthalmology 103 (1996) 205-206
9. Harooni M., McMillan T., and Refojo M. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase. Retina 18 (1998) 16-22
10. Tezel T.H., Del Priore L.V., and Kaplan H.J. Posterior vitreous detachment with dispase. Retina 18 (1998) 7-15
11. Yao X.Y., Hageman G.S., and Marmor M.F. Recovery of retinal adhesion after enzymatic perturbation of the interphotoreceptor matrix. Invest Ophthalmol Vis Sci 33 (1992) 498-503
12. Verstraeten T.C., Chapman C., Hartzer M., et al. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol 111 (1993) 849-854
13. Sebag J., Ansari R.R., and Suh K.I. Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients. Graefes Arch Clin Exp Ophthalmol 245 (2007) 576-580
14. Gandorfer A., Rohleder M., Sethi C., et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci 45 (2004) 641-647
15. Asami T., Terasaki H., Kachi S., et al. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema. Ophthalmology 111 (2004) 231-237
16. Trese M.T., Williams G.A., and Hartzer M.K. A new approach to stage 3 macular holes. Ophthalmology 107 (2000) 1607-1611
17. Liotta L.A., Goldfarb R.H., Brundage R., et al. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41 (1981) 4629-4636
18. Russell S.R., Shepherd J.D., and Hageman G.S. Distribution of glycoconjugates in the human retinal internal limiting membrane. Invest Ophthalmol Vis Sci 32 (1991) 1986-1995
19. Unal M., and Peyman G.A. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment. Retina 20 (2000) 69-75
20. Hesse L., Chofflet J., and Kroll P. Tissue plasminogen activator as a biochemical adjuvant in vitrectomy for proliferative diabetic vitreoretinopathy. Ger J Ophthalmol 4 (1995) 323-327
21. Castellino F.J., and Ploplis V.A. Human plasminogen: structure, activation, and function. In: Waisman D.M. (Ed). Plasminogen: Structure, Activation, and Regulation (2003), Kluwer Academic/Plenum, New York 3-17
22. Shi G.Y., and Wu H.L. Isolation and characterization of microplasminogen: a low molecular weight form of plasminogen. J Biol Chem 263 (1988) 17071-17075
23. de Smet M.D., Valmaggia C., Zarranz-Ventura J., and Willekens B. Microplasmin: ex vivo characterization of its activity in porcine vitreous. Invest Ophthalmol Vis Sci 50 (2009) 814-819
24. de Smet M.D., Valmaggia C., Zarranz-Ventura J., and Willekens B. Microplasmin induced vitreolysis in porcine eyes. Invest Ophthalmol Vis Sci 44 (2003) Abstract 3050
25. Hogan M.J., Kimura S.J., and Thygeson P. Signs and symptoms of uveitis. I. Anterior uveitis. Am J Ophthalmol 47 (1959) 155-170
26. Nussenblatt R.B., Palestine A.G., Chan C.C., and Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92 (1985) 467-471
27. Kakehashi A., Schepens C.L., de Sousa-Neto A., et al. Biomicroscopic findings of posterior vitreoschisis. Ophthalmic Surg 24 (1993) 846-850
28. Sebag J. Classifying posterior vitreous detachment: a new way to look at the invisible. Br J Ophthalmol 81 (1997) 521
29. Sjaarda R.N., Glaser B.M., Thompson J.T., et al. Distribution of iatrogenic retinal breaks in macular hole surgery. Ophthalmology 102 (1995) 1387-1392
30. Territo C., Gieser J.P., Wilson C.A., and Anand R. Influence of the cannulated vitrectomy system on the occurrence of iatrogenic sclerotomy retinal tears. Retina 17 (1997) 430-433
31. Rola A., Baiez Fidalgo C., Pastor Jimeno J.C., et al. Iatrogenic retinal breaks during vitrectomy: retrospective study [in Spanish]. Arch Soc Esp Oftalmol 78 (2003) 487-491
32. Moore J.K., Kitchens J.W., Smiddy W.E., et al. Retinal breaks observed during pars plana vitrectomy. Am J Ophthalmol 144 (2007) 32-36
33. Yamakiri K., Sakamoto T., Noda Y., et al. Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. Ophthalmology 114 (2007) 289-296
34. Cherfan G.M., Michels R.G., de Bustros S., et al. Nuclear sclerotic cataract after vitrectomy for idiopathic epiretinal membranes causing macular pucker. Am J Ophthalmol 111 (1991) 434-438
35. Thompson J.T. The role of patient age and intraocular gas use in cataract progression after vitrectomy for macular holes and epiretinal membranes. Am J Ophthalmol 137 (2004) 250-257